Literature DB >> 35322868

Retinal ultrastructural, electrophysiological, and microvascular morphological outcomes in diabetic macular edema treated with intravitreal bevacizumab.

Furkan Fatih Gulyesil1, Sibel Inan1, Hamidu Hamisi Gobeka2, Mehmet Cem Sabaner3, Anar Alizada1.   

Abstract

BACKGROUND: Investigation of retinal ultrastructural, electrophysiological, and microvascular morphological changes, as well as correlations between these changes and visual outcome in naïve diabetic macular edema (DME) patients after intravitreal bevacizumab therapy (IVBT).
METHODS: This prospective interventional study enrolled 31 DME patients' eyes treated with monthly IVBT for three months. Best-corrected visual acuity (BCVA) and intraocular pressure (IOP) were measured, and fundus fluorescein angiography, optical coherence tomography (OCT), microperimetry, as well as optical coherence tomography angiography (OCTA) were performed before and after IVBT. Patients were grouped based on BCVA improvement after three consecutive IVBT: group 1: > 10 letters, group 2: ≤ 5 letters, and group 3: between 6 and 10 letters.
RESULTS: Mean BCVA increased significantly from 34.2 to 39.9 letters (p < 0.001). Central macular thickness decreased significantly from 335.1 to 276.4 μm (p < 0.001). Fixation stability, retinal sensitivity, and local deficit all improved significantly (p < 0.001 for all). There was no statistically significant change in IOP (p = 0.665). Although OCTA parameters did not change significantly, lower foveal avascular zone (FAZ) area, higher foveal vessel density 300 μm area around FAZ and deep plexus vascular density were associated with highly improved BCVA, retinal sensitivity, and local deficit. Also, there were no significant intergroup differences in gender, age, baseline BCVA, HbA1c, IOP, phakic/pseudophakic lens ratio, concomitant hypertension, and superficial capillary plexus vascular density.
CONCLUSIONS: IVBT was associated with significantly improved BCVA, retinal ultrastructural integrity, and electrophysiological patterns in naive DME patients. Improvements in retinal electrophysiology correlated with ultrastructural improvements, which could be predicted using OCTA.
© 2022. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Diabetic macular edema; Intravitreal bevacizumab; Microperimetry; Optic coherence tomography angiography; Visual acuity

Year:  2022        PMID: 35322868     DOI: 10.1007/s11845-022-02979-y

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  30 in total

Review 1.  Pathophysiology of diabetic macular edema.

Authors:  Ajay Singh; Jay M Stewart
Journal:  Int Ophthalmol Clin       Date:  2009

Review 2.  Diabetic macular oedema.

Authors:  Gavin S Tan; Ning Cheung; Rafael Simó; Gemmy C M Cheung; Tien Yin Wong
Journal:  Lancet Diabetes Endocrinol       Date:  2016-08-03       Impact factor: 32.069

Review 3.  Current Clinical Application of Microperimetry: A Review.

Authors:  Ainhoa Molina-Martín; Rafael J Pérez-Cambrodí; David P Piñero
Journal:  Semin Ophthalmol       Date:  2017-10-09       Impact factor: 1.975

4.  Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye.

Authors:  Yali Jia; Steven T Bailey; Thomas S Hwang; Scott M McClintic; Simon S Gao; Mark E Pennesi; Christina J Flaxel; Andreas K Lauer; David J Wilson; Joachim Hornegger; James G Fujimoto; David Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

Review 5.  Diabetic retinopathy.

Authors:  Ning Cheung; Paul Mitchell; Tien Yin Wong
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

Review 6.  Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010.

Authors:  Janet L Leasher; Rupert R A Bourne; Seth R Flaxman; Jost B Jonas; Jill Keeffe; Kovin Naidoo; Konrad Pesudovs; Holly Price; Richard A White; Tien Y Wong; Serge Resnikoff; Hugh R Taylor
Journal:  Diabetes Care       Date:  2016-09       Impact factor: 19.112

7.  Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.

Authors:  Khalil Ghasemi Falavarjani; Nicholas A Iafe; Jean-Pierre Hubschman; Irena Tsui; Srinivas R Sadda; David Sarraf
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

8.  VEGF164 is proinflammatory in the diabetic retina.

Authors:  Susumu Ishida; Tomohiko Usui; Kenji Yamashiro; Yuichi Kaji; Ednan Ahmed; Karen G Carrasquillo; Shiro Amano; Tetsuo Hida; Yoshihisa Oguchi; Anthony P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

9.  Efficacy of intravitreal triamcinolone acetonide in long standing diabetic macular edema: a microperimetry and optical coherence tomography study.

Authors:  Pierluigi Grenga; Stefano Lupo; Daniela Domanico; Enzo Maria Vingolo
Journal:  Retina       Date:  2008-10       Impact factor: 4.256

Review 10.  Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.

Authors:  Pedro Romero-Aroca; Marc Baget-Bernaldiz; Alicia Pareja-Rios; Maribel Lopez-Galvez; Raul Navarro-Gil; Raquel Verges
Journal:  J Diabetes Res       Date:  2016-09-28       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.